
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Theracurmin is a nano-sized curcumin formulation with 27 times higher bioavailability than standard curcumin. It targets inflammatory pathways through enhanced NF-κB inhibition and provides superior antioxidant protection due to improved cellular uptake.

Reported Benefits (Provisional)
Origin & History

Theracurmin is a nano-formulated curcumin, derived from turmeric, designed to improve solubility and absorption. The nano-emulsification process allows for smaller particle size, enhancing its bioavailability.
Research Narrative (Provisional)
Clinical trials have demonstrated that Theracurmin significantly increases curcumin levels in the bloodstream compared to regular curcumin. Systematic reviews highlight its potential in managing inflammation and oxidative stress.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Theracurmin is a nano-formulated curcumin preparation where curcumin (the primary bioactive polyphenol from Curcuma longa) is dispersed in colloidal submicron particles (~100-200nm) using glycerin and gum ghatti as carriers. The active curcuminoid content is standardized to approximately 27-30mg curcumin per 90mg Theracurmin dose, comprising curcumin (~77%), demethoxycurcumin (~17%), and bisdemethoxycurcumin (~3-5%). It contains no significant macronutrients, fiber, or conventional vitamins/minerals. Key bioactive: curcumin (diferuloylmethane, C21H20O6). Bioavailability is the defining characteristic — Theracurmin demonstrates approximately 27-fold greater bioavailability compared to standard curcumin powder, achieving plasma concentrations of ~200-300 ng/mL at 90mg dosing due to the colloidal nanoparticle technology reducing particle size and increasing aqueous dispersibility. Cmax is typically reached within 1-2 hours post-ingestion.
Reported Mechanism (Provisional)
Theracurmin's nano-particle formulation enables superior gastrointestinal absorption and cellular penetration of curcumin. The enhanced bioavailable curcumin inhibits NF-κB signaling, reducing pro-inflammatory cytokines like TNF-α and IL-6. It also activates Nrf2 pathways to upregulate antioxidant enzymes including glutathione peroxidase and superoxide dismutase.
Clinical Narrative (Provisional)
Human studies demonstrate Theracurmin achieves 27-fold higher blood curcumin levels compared to standard curcumin powder. A 8-week randomized trial with 50 participants showed 58% reduction in joint pain scores with 180mg daily Theracurmin. Additional studies report improved inflammatory markers including 40% reduction in C-reactive protein levels. Most clinical evidence comes from small-scale trials requiring larger confirmatory studies.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







